Search

Your search keyword '"Merck Sharp & Dohme Corp. -- Intellectual property"' showing total 497 results
Start Over Descriptor "Merck Sharp & Dohme Corp. -- Intellectual property"
497 results on '"Merck Sharp & Dohme Corp. -- Intellectual property"'

2. 'Combination Of A Pd-1 Antagonist And A Vegfr/Fgfr/Ret Tyrosine Kinase Inhibitor For Treating Cancer' in Patent Application Approval Process (USPTO 20220023285)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Cancer -- Care and treatment, Palladium -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DENKER, Andrew Evan (North Wales, PA, US); HORI, [...]

Published
2022

3. Researchers Submit Patent Application, 'Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors', for Approval (USPTO 20210361662)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, HIV (Viruses), Antiviral agents, Anti-HIV agents, Atazanavir -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

4. Researchers Submit Patent Application, 'Formulations Of Anti-Rsv Antibodies And Methods Of Use Thereof', for Approval (USPTO 20210324052)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Methods -- Intellectual property, Viral antibodies -- Methods, Amino acids -- Methods -- Intellectual property, Antibodies -- Methods, Physical fitness -- Methods, Pharmaceutical industry -- Intellectual property, Health, L-Lysine (Dietary supplement) -- Intellectual property
Abstract

2021 NOV 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

5. Patent Issued for Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer (USPTO 11147806)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Endothelial growth factors -- Reports, Women -- Health aspects, Tyrosine -- Intellectual property -- Reports, Phenols -- Intellectual property -- Reports, Cancer -- Care and treatment -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Denker, Andrew [...]

Published
2021

6. Researchers Submit Patent Application, 'Prmt5 Inhibitors', for Approval (USPTO 20210309688)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, B cells, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Lim, [...]

Published
2021

7. Patent Issued for Prefilled disposable injection device (USPTO 11123499)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness -- Reports, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2021

8. Researchers Submit Patent Application, 'Inhibitors Of Histone Deacetylase Useful For The Treatment Or Prevention Of Hiv Infection', for Approval (USPTO 20210276992)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, HIV (Viruses), Antiviral agents, Anti-HIV agents, Darunavir, Atazanavir -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, HIV infection, Health
Abstract

2021 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

9. Patent Issued for Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase (USPTO 11096930)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Tryptophan -- Intellectual property -- Reports, Physical fitness -- Reports, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2021

10. Patent Issued for 5-alkyl pyrrolidine orexin receptor agonists (USPTO 11098029)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Bogen, Stephane L. (Somerset, NJ, US), Clausen, [...]

Published
2021

11. Patent Issued for PRMT5 inhibitors (USPTO 11098059)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, B cells -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Altman, Michael [...]

Published
2021

12. Patent Issued for Anti-LAG3 antibodies and antigen-binding fragments (USPTO 11045547)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Antigens, Amino acids -- Intellectual property, B cells, Antibodies, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 JUL 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2021

13. Court of Justice of the European Union Judgment: Merck Sharp & Dohme Corporation (C-567|16)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Merck Sharp & Dohme Ltd. -- Intellectual property, Judgments, Pharmaceutical industry -- Intellectual property, News, opinion and commentary, European Union -- Intellectual property, European Union. Court of Justice of the European Union -- Intellectual property, European Union. European Parliament -- Intellectual property, European Union. European Commission -- Intellectual property
Abstract

Luxembourg: Court of Justice of the European Union has issued the following Judgment: JUDGMENT OF THE COURT (Seventh Chamber) 7 December 2017 (*) (Reference for a preliminary ruling -- Industrial [...]

Published
2023

14. Patent Application Titled 'Combinations of PD-1 Antagonists and Benzo[b]thiophene STING Agonists for Cancer Treatment' Published Online (USPTO 20210130466)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Thiophene, Cancer -- Care and treatment, Bites and stings, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

15. Patent Application Titled 'Recombinant Expression Of Chlamydia Momp Antigen' Published Online (USPTO 20210093703)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antigens, Amino acids -- Intellectual property, Chlamydia, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

16. Researchers Submit Patent Application, 'Tyrosine-Specific Functionalized Insulin And Insulin Analogs', for Approval (USPTO 20210002345)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Insulin -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 JAN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

17. Researchers Submit Patent Application, 'Pharmaceutical Compositions Of Tedizolid Phosphate', for Approval (USPTO 20200360360)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Bacterial infections, Phosphates -- Intellectual property, Physical fitness, Infection, Tedizolid -- Intellectual property, Pharmaceutical industry -- Intellectual property, Methicillin -- Intellectual property, Florfenicol, Health
Abstract

2020 DEC 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2020

18. Researchers Submit Patent Application, 'Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer', for Approval (USPTO 20200325228)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Axitinib, Endothelial growth factors, Neovascularization, Cancer, Women's health, Palladium -- Intellectual property, Pembrolizumab, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Martini, [...]

Published
2020

20. Patent Issued for Combination Of A PD-1 Antagonist And An ALK Inhibitor For Treating Cancer (USPTO 10,695,426)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment -- Reports, Crizotinib -- Reports, Cancer -- Reports, Women's health -- Reports, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Das-Young, Leena [...]

Published
2020

21. 'Scoring Methods For Anti-Pd Therapy Eligibility And Compositions For Performing Same' in Patent Application Approval Process (USPTO 20200200759)

Subjects
Bristol-Myers Squibb Co. -- Intellectual property, Merck Sharp & Dohme Corp. -- Intellectual property, Women's health -- Methods, Nivolumab -- Methods, Avelumab -- Intellectual property -- Methods, Palladium -- Methods -- Intellectual property, Pembrolizumab -- Methods, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUL 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Kulangara, Karina (Carpinteria, CA); Zhang, Nancy (Thousand Oaks, [...]

Published
2020

23. Patent Application Titled 'Pharmaceutical Compositions Containing Doravirine, Tenofovir Disoproxil Fumarate And Lamivudine' Published Online (USPTO 20200179291)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Lamivudine -- Intellectual property, Tenofovir, Pharmaceutical industry -- Intellectual property, Health
Abstract

2020 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2020

24. Patent Issued for Recombinant Expression Of Chlamydia MOMP Antigen (USPTO 10,675,339)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antigens, Chlamydia, Amino acids -- Intellectual property, Health, Women's issues/gender studies
Abstract

2020 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Zhang, Lan (Chalfont, PA); Wen, Zhiyun (Devon, PA); Przysiecki, [...]

Published
2020

26. Patent Issued for Process For Making Chloro-Substituted Nucleoside Phosphoramidate Compounds (USPTO 10,597,422)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Nucleosides, Physical fitness, Hepatitis C virus, Infection, Pharmaceutical industry -- Intellectual property, Obesity, Editors, Health
Abstract

2020 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors DiRocco, Daniel (Lebanon, NJ); Klapars, Artis (Edison, [...]

Published
2020

27. Patent Issued for Combination Of A PD-1 Antagonist And A VEGFR Inhibitor For Treating Cancer (USPTO 10,570,202)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Axitinib, Endothelial growth factors, Neovascularization, Cancer, Women's health, Pembrolizumab, Pharmaceutical industry -- Intellectual property, Containers, Editors, Health, Women's issues/gender studies
Abstract

2020 MAR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Martini, Jean-Francois Andre (Carlsbad, CA); Tarazi, Jamal Christo (San [...]

Published
2020

28. Patent Issued for Prefilled Disposable Injection Device (USPTO 10,543,317)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Obesity, Containers, Editors, Health
Abstract

2020 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Basile, Peter A. (Bloomsbury, NJ); Persak, Steven [...]

Published
2020

30. Researchers Submit Patent Application, 'Aryl Sulfonamides As Blt1 Antagonists', for Approval (USPTO 20220363656)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Heart diseases, Sulfonamides -- Intellectual property, Hypoglycemic agents, Type 2 diabetes, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health
Abstract

2022 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Han, [...]

Published
2022

34. 'Hydroxypyrrolidine-Substituted Arylsulfonamide Compounds With Selective Activity In Voltage-Gated Sodium Channels' in Patent Application Approval Process (USPTO 20220305035)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Biological sciences, Business
Abstract

2022 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors Layton, Mark E. (Harleysville, PA, US); Peng, Xuanjia [...]

Published
2022

35. 'Compositions Comprising Streptococcus Pneumoniae Polysaccharide-Protein Conjugates And Methods Of Use Thereof' in Patent Application Approval Process (USPTO 20220296695)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Bacterial pneumonia -- Methods, Polysaccharides -- Intellectual property -- Methods, B cells -- Methods, Pneumonia -- Methods, Vaccines -- Intellectual property -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors Abeygunawardana, Chitrananda (Ambler, PA, US); Cui, Yadong Adam (Norristown, [...]

Published
2022

36. Australian Patent Office Decision: Bayer Pharma Aktiengesellschaft [2022] APO 7 (7 February 2022)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Drospirenone -- Intellectual property, Contraceptives -- Intellectual property, Patents, Ethinyl estradiol -- Intellectual property, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, News, opinion and commentary
Abstract

Canberra: Australian Patent Office has issued the following decision: AUSTRALIAN PATENT OFFICE Bayer Pharma Aktiengesellschaft [2022] APO 7 Patent: 780330 Title: Pharmaceutical combination of ethinylestradiol and drospirenone for use as [...]

Published
2022

37. Patent Issued for Prefilled Disposable Injection Device (USPTO 10,500,338)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Obesity, Containers, Editors, Health
Abstract

2019 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventor Berenshteyn, Annaniy (Edgewater, NJ), filed on April [...]

Published
2019

38. Patent Issued for Pegylated Interleukin-10 (USPTO 10,471,126)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Interleukins, Physical fitness, B cells, Amino acids, Pharmaceutical industry -- Intellectual property, Obesity, Editors, Health
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Lee, Seoju (Madison, AL); Wylie, David C. [...]

Published
2019

39. Patent Issued for Process For Preparing Beta-Lactamase Inhibitor Hydroxylurea Intermediates (USPTO 10,464,937)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Beta lactamases, Pharmaceutical industry -- Intellectual property, Parks, Obesity, Editors, Health
Abstract

2019 NOV 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

40. 'Treating Cancer With A Combination Of A Pd-1 Antagonist And An Il-27 Antagonist' in Patent Application Approval Process (USPTO 20190270802)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer treatment, Cancer, Women's health, Palladium, Pharmaceutical industry -- Intellectual property, Containers, Anopheles, Editors, Women, Health, Women's issues/gender studies
Abstract

2019 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Shifrin, Nataliya Tovbis (Redwood City, CA); de Waal [...]

Published
2019

41. Researchers Submit Patent Application, 'Process For Preparing Beta-Lactamase Inhibitor Hydroxylurea Intermediates', for Approval (USPTO 20190233421)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Beta lactamases, Pharmaceutical industry -- Intellectual property, Parks, Obesity, Editors, Health
Abstract

2019 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

42. Patent Issued for Preparation And Use Of 7a-Heterocycle Substituted-6,6-Difluoro Bicyclic Himbacine Derivatives As PAR-1 Receptor Antagonists (USPTO 10,322,140)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Thrombin, Clopidogrel, Physical fitness, Vorapaxar, Pharmaceutical industry -- Intellectual property, Obesity, Editors, Health
Abstract

2019 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

43. Patent Issued for 7-Aminocephem Derivative Compounds (USPTO 10,308,666)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Physical fitness, Lactams, Pharmaceutical industry -- Intellectual property, Antibacterial agents, Cephalosporins, Obesity, Editors, Beta lactamases, Health
Abstract

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2019

44. 'Recombinant Expression Of Chlamydia Momp Antigen' in Patent Application Approval Process (USPTO 20190046626)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Antigens, Amino acids, Women's health, Women, Health, Chlamydia, Editors, Health, Women's issues/gender studies
Abstract

2019 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Zhang, Lan (Chalfont, PA); Wen, Zhiyun (Devon, PA); [...]

Published
2019

45. Researchers Submit Patent Application, 'Antigenic Glycoprotein E Polypeptides, Compositions, And Methods Of Use Thereof', for Approval (USPTO 20220280636)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Amino acids -- Intellectual property -- Methods, Vaccines -- Intellectual property -- Methods, Biopolymers -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Fridman, Arthur [...]

Published
2022

46. Patent Issued for Well plate assembly with pressure release mechanism (USPTO 11426730)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2022 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Ciolino, William James (Union Town, NJ, US), Nguyen-DeMary, Tinh (Milltown, [...]

Published
2022

47. Patent Application Titled 'Process for Separating Antigen-Binding Polypeptide Monomers Comprising One or More Immunoglobulin Single Variable Domains from Aggregates of Said Monomers' Published Online (USPTO 20220267370)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Antigens, Amino acids -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2022

48. 'Methods And Assemblies For Preparing And Dispensing Lyospheres Of Pharmaceutical Compositions' in Patent Application Approval Process (USPTO 20220265558)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Vaccines -- Intellectual property -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors Bhambhani, Akhilesh (Foster City, CA, US); Jones, Morrisa (Upper [...]

Published
2022

49. Researchers Submit Patent Application, 'Anti-Lag3 Antibodies And Antigen-Binding Fragments', for Approval (USPTO 20220257762)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Antigens, Amino acids -- Intellectual property, B cells, Antibodies, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2022 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors De Waal [...]

Published
2022

50. Researchers Submit Patent Application, 'Glycan-Based Antibody-Drug Conjugates', for Approval (USPTO 20220242970)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biopharmaceutics -- Intellectual property, Amino acids -- Intellectual property, Drug approval, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2022 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Davidson, Robert [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results